Antivascular and anticancer activity of dihalogenated A-ring analogues of combretastatin A-4

Royal Society of Chemistry (RSC) - Tập 1 Số 3 - Trang 202 - 2010
Thomas M. Beale1, R. M. Myers1, J.W. Shearman1, D. Stephen Charnock‐Jones2,3, James D. Brenton4, Fanni Gergely4, Steven V. Ley1
1Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, United Kingdom
2Department of Obstetrics and Gynaecology, University of Cambridge, The Rosie Hospital, Cambridge, United Kingdom
3National Institute for Health Research, Cambridge Comprehensive Biomedical Research Centre,Cambridge,UK
4Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way,Cambridge,United Kingdom,

Tóm tắt

Từ khóa


Tài liệu tham khảo

Altmann, 2001, Curr. Opin. Chem. Biol., 5, 424, 10.1016/S1367-5931(00)00225-8

Jordan, 2004, Nat. Rev. Cancer, 4, 253, 10.1038/nrc1317

Weaver, 2005, Cancer Cell, 8, 7, 10.1016/j.ccr.2005.06.011

Schmidt, 2007, Drug Resist. Updates, 10, 162, 10.1016/j.drup.2007.06.003

Steinberg, 2008, Clin. Ther., 30, 1590, 10.1016/j.clinthera.2008.09.015

Canta, 2009, Curr. Med. Chem., 16, 1315, 10.2174/092986709787846488

Schiff, 2009, Nat. Rev. Clin. Oncol., 6, 596, 10.1038/nrclinonc.2009.128

Mahindroo, 2006, Expert Opin. Ther. Pat., 16, 647, 10.1517/13543776.16.5.647

Risinger, 2009, Cancer Treat. Rev., 35, 255, 10.1016/j.ctrv.2008.11.001

Carlson, 2008, Expert Opin. Invest. Drugs, 17, 707, 10.1517/13543784.17.5.707

Pettit, 1989, Experientia, 45, 209, 10.1007/BF01954881

Lin, 1989, Biochemistry, 28, 6984, 10.1021/bi00443a031

Cushman, 1992, J. Med. Chem., 35, 2293, 10.1021/jm00090a021

Lee, 2010, J. Med. Chem., 53, 325, 10.1021/jm901268n

Dark, 1997, Cancer Res., 57, 1829

Griggs, 2001, Lancet Oncol., 2, 82, 10.1016/S1470-2045(00)00224-2

Schwartz, 2009, Clin. Cancer Res., 15, 2594, 10.1158/1078-0432.CCR-08-2710

Heath, 2009, Nature Reviews Clinical Oncology, 6, 395, 10.1038/nrclinonc.2009.52

Siemann, 2009, Cell Tissue Res., 335, 241, 10.1007/s00441-008-0646-0

Cooney, 2006, Nat. Clin. Pract. Oncol., 3, 682, 10.1038/ncponc0663

Ivy, 2009, Nature Reviews Clinical Oncology, 6, 569, 10.1038/nrclinonc.2009.130

Jain, 2005, Science, 307, 58, 10.1126/science.1104819

Rüegg, 2006, Biochim. Biophys. Acta, 1765, 155

Tozer, 2005, Nat. Rev. Cancer, 5, 423, 10.1038/nrc1628

Singh, 2009, Synthesis, 2471, 10.1055/s-0029-1216891

Bhattacharyya, 2008, Med. Res. Rev., 28, 155, 10.1002/med.20097

Pan, 2009, Nat. Prod. Rep., 26, 1251, 10.1039/b910940d

Apers, 2003, Phytochem. Rev., 2, 201, 10.1023/B:PHYT.0000045497.90158.d2

Gaukroger, 2003, Org. Biomol. Chem., 1, 3033, 10.1039/B306878A

Tron, 2006, J. Med. Chem., 49, 3033, 10.1021/jm0512903

Andreu, 1998, Biochemistry, 37, 8356, 10.1021/bi9728553

Pettit, 2005, J. Nat. Prod., 68, 1450, 10.1021/np058038i

Monaco, 1999, Int. J. Quantum Chem., 71, 57, 10.1002/(SICI)1097-461X(1999)71:1<57::AID-QUA6>3.0.CO;2-I

Metrangolo, 2008, Angew. Chem., Int. Ed., 47, 6114, 10.1002/anie.200800128

Auffinger, 2004, Proc. Natl. Acad. Sci. U. S. A., 101, 16789, 10.1073/pnas.0407607101

Lu, 2009, J. Med. Chem., 52, 2854, 10.1021/jm9000133

Hentschel, 2010, Synthesis, 42, 181

Manzo, 2003, Org. Lett., 5, 4591, 10.1021/ol035721s

Karjala, 2005, Cancer Res., 65, 3040, 10.1158/0008-5472.CAN-04-4369

Shearman, 2010, Tetrahedron Lett., 10.1016/j.tetlet.2010.07.016

Metrangolo, 2008, Science, 321, 918, 10.1126/science.1162215

Emmanuvel, 2006, Tetrahedron Lett., 47, 4793, 10.1016/j.tetlet.2006.05.062

Singh, 1989, J. Org. Chem., 54, 4105, 10.1021/jo00278a023

Pettit, 1995, J. Med. Chem., 38, 1666, 10.1021/jm00010a011

Orsini, 1997, Carbohydr. Res., 301, 95, 10.1016/S0008-6215(97)00087-6

Xing, 2005, Chem. Res. Toxicol., 18, 154, 10.1021/tx049721s

Hall, 2008, Bioorg. Med. Chem. Lett., 18, 5146, 10.1016/j.bmcl.2008.07.070

Paris, 1983, Appl. Environ. Microbiol., 45, 1153, 10.1128/AEM.45.3.1153-1155.1983